REGN Jan 2026 910.000 call
| Previous close | 193.20 |
| Open | 193.20 |
| Bid | 211.00 |
| Ask | 220.00 |
| Strike | 910.00 |
| Expiry date | 2026-01-16 |
| Day's range | 193.20 - 193.20 |
| Contract range | N/A |
| Volume | |
| Open interest | 2 |
Insider MonkeyRegeneron Pharmaceuticals, Inc. (REGN): A Buzzing AI Health Stock to Add to Your Portfolio
We recently compiled a list of the 10 Buzzing AI Health Stocks. In this article, we are going to take a look at where Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) stands against the other buzzing AI health stocks. The economic impact of AI is projected to be substantial, particularly in regions like China and North America, which are […]
ZacksSanofi, Regeneron's Dupixent Gets FDA Approval for COPD
Sanofi and Regeneron's Dupixent becomes the first biologic treatment approved for COPD in the United States.
- Insider Monkey
Jim Cramer on Regeneron Pharmaceuticals Inc. (REGN): ‘Leerink Analysts Downgraded Regeneron To A Market Perform Hold After A Negative Eylea 2mg Biosimilar Preliminary Injunction Ruling’
We recently compiled a list of the Cramer’s Morning Thoughts: 20 Stocks to Watch. In this article, we are going to take a look at where Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) stands against the other stocks to watch according to Jim Cramer. In a recent episode of Mad Money, Jim Cramer explains that if you’re investing with […]
